Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression

PURPOSE: To determine the prognostic value of vimentin in triple negative breast cancer (TNBC) patients, specifically in relation to chemotherapy regimen and p53 mutant expression. PATIENT AND METHODS: We retrospectively analyzed the association of pre-treatment tumor expression of vimentin with 48-...

Descripción completa

Detalles Bibliográficos
Autores principales: Purwanto, Ibnu, Leo, Benedreky, Hutajulu, Susanna Hilda, Kurnianda, Johan, Taroeno-Hariadi, Kartika Widayati, Hardianti, Mardiah Suci, Satiti, Amanda Dania, Dwianingsih, Ery Kus, Heriyanto, Didik Setyo, Widodo, Irianiwati, Aryandono, Teguh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390761/
https://www.ncbi.nlm.nih.gov/pubmed/37533591
http://dx.doi.org/10.2147/BCTT.S418696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390761/
https://www.ncbi.nlm.nih.gov/pubmed/37533591
http://dx.doi.org/10.2147/BCTT.S418696

Ejemplares similares